Cargando…
The Equipoise Between the Treatment of Glioblastoma and the Risk of Secondary Acute Myelogenous Leukemia: An Illustrative Case Report
We present a case report of a 56-year-old woman who was diagnosed with biopsy-proven left thalamic glioblastoma multiforme (GBM). She was treated with standard concurrent chemotherapy and radiation, as well as a 2-year period of adjuvant temozolomide. She relapsed 2 ½ years after starting her initia...
Autores principales: | Harari-Turquie, Moises, Moturi, Krishna Rekha, Horton, Darrell D., Rabinowitz, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440052/ https://www.ncbi.nlm.nih.gov/pubmed/37596951 http://dx.doi.org/10.1177/23247096231193266 |
Ejemplares similares
-
Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy
por: Sasankan, Shenthol, et al.
Publicado: (2020) -
Glycemic equipoise
por: Kalra, Sanjay, et al.
Publicado: (2017) -
Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009) -
What to do with the equipoise?
por: Knol, Wiebe G, et al.
Publicado: (2019) -
Applications of Microarray Technology to Acute Myelogenous Leukemia
por: Goswami, Rashmi S., et al.
Publicado: (2008)